Back
PT Indofood CBP Sukses Makmur Tbk Vs. Nutex Health Industry Stock Comparison
Buy
67
PIFFY
PT Indofood CBP Sukses Makmur Tbk
Last Price:
15.38
Seasonality Move:
1.76%
Buy
58
NUTX
Nutex Health
Last Price:
32.38
Seasonality Move:
-16.36%
Buy
67
PT Indofood CBP Sukses Makmur Tbk (PIFFY)
is a Buy
Is PT Indofood CBP Sukses Makmur Tbk a Buy, Sell or Hold?
- The current PT Indofood CBP Sukses Makmur Tbk [PIFFY] share price is $15.38. The Score for PIFFY is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- PIFFY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Nutex Health (NUTX)
is a Buy
Is Nutex Health a Buy, Sell or Hold?
- The current Nutex Health [NUTX] share price is $32.62. The Score for NUTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NUTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PIFFY Stock Price Chart
What is PT Indofood CBP Sukses Makmur Tbk's stock price today?
-
The PT Indofood CBP Sukses Makmur Tbk share price today is $15.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PIFFY is experiencing slight buying pressure.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $32.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUTX is experiencing selling pressure, which indicates risk of future bearish movement.
PIFFY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 99.86 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.1 - 15.76) | Buy |
| Bollinger Bands (100): | (11.74 - 14) | Buy |
NUTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.83 | Buy |
| Relative Strength Index (14 RSI): | 62.26 | Buy |
| Chaikin Money Flow: | -85516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20 - 28.76) | Buy |
| Bollinger Bands (100): | (8.72 - 24.98) | Buy |
PIFFY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.38 | Sell |
| 20-day SMA: | 14.96 | Buy |
| 50-day SMA: | 13.38 | Buy |
| 200-day SMA: | 13.54 | Buy |
| 8-day EMA: | 15.34 | Buy |
| 20-day EMA: | 14.83 | Buy |
| 50-day EMA: | 13.89 | Buy |
| 200-day EMA: | 13.4 | Buy |
NUTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.14 | Buy |
| 20-day SMA: | 25.59 | Buy |
| 50-day SMA: | 23.17 | Buy |
| 200-day SMA: | 14.02 | Buy |
| 8-day EMA: | 29.96 | Buy |
| 20-day EMA: | 26.54 | Buy |
| 50-day EMA: | 22.9 | Buy |
| 200-day EMA: | 24.52 | Buy |
PT Indofood CBP Sukses Makmur Tbk Earnings Growth & PIFFY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nutex Health Earnings Growth & NUTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $1.74 per share.
PT Indofood CBP Sukses Makmur Tbk Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutex Health Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||